Release from Memphis Pharmaceuticals (MPCI.CA) Concerning the BoD Decisions
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
With reference to the announcement published on the trading screens on 01/07/2026 regarding the decisions of the company's Board of Directors at its meeting held on 30/06/2026, a release was sent from the company.
Release from the Company (205 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
With reference to the announcement published on the trading screens on 01/07/2026 regarding the decisions of the company's Board of Directors at its meeting held on 30/06/2026, a release was sent from the company.
Release from the Company (205 KB)
Comments